首页> 外文期刊>Heart, lung & circulation >Extra corporeal membrane oxygenation as right heart support following left ventricular assist device placement: a new cannulation technique.
【24h】

Extra corporeal membrane oxygenation as right heart support following left ventricular assist device placement: a new cannulation technique.

机译:左心室辅助装置放置后,额外的膜状膜氧合作为右心支持:一种新的插管技术。

获取原文
获取原文并翻译 | 示例
           

摘要

Extracorporeal membrane oxygenation is an established treatment for acute respiratory failure, or low cardiac output syndrome. This can be veno-venous, in which de-oxygenated blood is drained from the venous system and oxygenated before being returned to the venous system, and veno-arterial where the re-oxygenated venous blood is returned to the arterial system. Haemorrhage, sepsis and thrombo-embolism are common and potentially lethal complications. Left ventricular assist devices are a continually evolving technology, that may be used as a bridge to transplantation or destination therapy in end-stage cardiac failure. The VentrAssist? left ventricular assist device is a small implantable, continuous flow centrifugal pump, that is controlled and powered by a percutaneous lead. However, in these patients, right heart failure may present as an acute event following weaning from cardiopulmonary bypass (CPB), or post-operatively in the intensive care unit. Patients who do not respond to inotropes and pulmonary vasodilators may need a right ventricular assist device (RVAD). We report a successful case of right heart assist extra corporeal membrane oxygenation used as temporary right heart support in combination with a VentrAssist? left ventricular assist device. The use of right heart assist extra corporeal membrane oxygenation to help a failing right heart during left ventricular assist device placement is not new, however, our technique describes a novel method of cannulation of the femoral vein and pulmonary trunk via a tunnelled vascular tube graft, which allows the chest to be closed whilst on right heart support, and decannulation to proceed without resternotomy. This technique has also been used successfully subsequent to this.
机译:体外膜氧合是一种针对急性呼吸衰竭或低心输出量综合征的既定治疗方法。这可以是静脉-静脉,其中脱氧的血液从静脉系统中排出并在返回到静脉系统之前被充氧,以及静脉-动脉,其中再氧化的静脉血液返回到动脉系统。出血,败血症和血栓栓塞是常见且可能致命的并发症。左心室辅助设备是一项不断发展的技术,可以用作心衰终末期移植或目的地治疗的桥梁。 VentrAssist?左心室辅助设备是一种小型可植入的连续流离心泵,由经皮导线控制和驱动。但是,在这些患者中,右心衰竭可能是从体外循环(CPB)断奶后或在重症监护室中发生的急性事件。对正性肌力药和肺血管扩张药无反应的患者可能需要右心室辅助装置(RVAD)。我们报告了一个成功的右心辅助案例,与VentrAssist结合用作临时右心支持的右心膜额外膜外充氧。左心室辅助装置。在放置左心室辅助装置期间使用右心辅助膜外充氧来帮助右心衰竭并不是什么新鲜事,但是,我们的技术描述了一种通过隧道式血管导管移植股静脉和肺干的新方法,可以在右心支撑下关闭胸腔,并且无需进行再切开就可以进行脱皮术。此后,该技术也已成功使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号